Combined effect of tamoxifen or interferon-β and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines

Tumor Biology

Volumn 18, Issue 1, 1997, Pages 22-29

  Coradini, Danila ^a   Biffi, Anna ^a   Pellizzaro, Cinzia ^a   Pirronello, Ester ^a   Di Fronzo, Giovanni ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

Breast cancer; Cell lines; Factors; Interferon ; Tamoxifen

Indexed keywords

BETA INTERFERON; FENRETINIDE; HORMONE RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0031012787     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218012     Document Type: Article

References (46)

1. Vieira AV, Schneider WJ, Vieira PM: Retinoids: Transport, metabolism, and mechanisms of actions, J Endocrinol 1995;146:201-207.
2. Sporn MB, Roberts AB, Goodman DB: The Retinoids, New York, Raven Press, 1994.
3. Sporn MB, Newton DL: Chemo-prevention of cancer with retinoids, Fed Proc 1979;38:2528-2534.
4. Bollag W, Holdener EE: Retinoids in cancer prevention and therapy, Ann Oncol 1992;3:513-526.
5. Moon RC, Thompson HJ, Bccci PJ, Grubbs CH, Gander RJ, Newton DL, Smith CC, Sporn MB: N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat, Cancer Res 1979; 39:1339-1346.
6. Dowlatshahi K, Metha RG, Thomas CT, Dinger NM, Moon RC: Therapeutic effect of N-(4-hydroxyphc-nyl) retinamide on N-methyl-N-ni-trosurca-induced rat mammary cancer, Cancer Lett 1989;47:187-192.
7. Halter S, Frakcr L, Adcock D: Effect of retinoids on xenotransplantcd human mammary carcinoma cells in athymie mice, Cancer Res 1988;48: 3733-3736.
8. Veronesi U, De Palo G, Costa A, Formelli F, Marubini E, Del Vecchio M: Chemoprcvention of breast cancer with retinoids, J Natl Cancer Inst Monogr 1992;12:93-97.
9. Costa A: Breast cancer chemoprcvention, Eur J Cancer 1993;29A: 589-592.
10. McCormick DL, Moon RC: Reti-noid-tamoxifen interaction in mammary cancer chemoprcvention, Carcinogenesis 1986:7:193-196.
11. Breast Cancer Trials Committee, Scottish Cancer Trials Office: Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial, Lancet 1987:ii: 171-175.
12. Powell TJ, Jones AL, Ashley SE, O’Brien MER, Tidy VA, Treleaven J, Cosgrove D, Nash AG, Sacks N, Baum M, McKinna JA, Davcy JB: The Royal Marsden Hospital pilot tamoxifen chcmoprevention trial, Breast Cancer Res Treat 1994;31: 73-82.
13. Fontana JA: Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation, Exp Cell Biol 1987;55: 136-144.
14. Evans RM: The steroid and thyroid hormone receptor superfamily, Science 1988:240:889-895.
15. Borden EC, Ball LA: Interferons: Biochemical, cell growth inhibitory and immunological effects, Prog He-matol 1981;8:299-339.
16. Lippman SM, Parkinson DR, Itri LM: 13-G, s-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin, J Natl Cancer Inst 1992;84:235-241.
17. Voravud N, Lippman SM, Weber RAS: Phasc-II study of 13-m-reti-noic acid plus intcrfcron-a in recurrent head and neck cancer, Invest New Drugs 1993; 11:57-60.
18. Rinaldi DA, Lippman S, Burris HA: Phasc-II study of 13-d.s-retinoic acid and intcrfcron-a2a in patients with advanced squamous cell lung cancer, Anticancer Drugs 1993;4: 33-36.
19. Dhingra K, Papadopoulos N, Lippman SM: Phase II study of alpha-interferon and 13-a.v-retinoic acid in metastatic melanoma, Invest New Drugs 1993;11:39-43.
20. Lippman SM, Kavanagh JJ, Par-edes-Espinoza M: 13-G.v-rctinoic acid plus interferon-a2a in locally advanced squamous cell carcinoma of the cervix, J Natl Cancer Inst 1993;85:499-500.
21. Coradini D, Bifïi A, Pirronello E, Di Fronzo G: The effect of a-, β- and y-interferon on the growth of breast cancer cell lines, Anticancer Res 1994;14:1779-1784.
22. Soule HD, Vazques J, Long A: A human cell line from a pleural effusion derived from a breast carcinoma, J Natl Cancer Inst 1973;51: 1409-1416.
23. Keydar I, Chen L, Karby S: Establishment and characterization of a cell line of human breast carcinoma, Eur J Cancer 1979;15:659-663.
24. Cailleau R, Young R, Olive M: Breast tumor cell lines from pleural effusion, J Natl Cancer Inst 1974; 53:661-674.
25. Lasfargues EY, Ozzcllo L: Cultivation of human breast carcinoma, J Natl Cancer Inst 1958;21:1131-1147.
26. Coradini D, Cappelletti V, Granata G, Di Fronzo G: Activity of tamoxifen and its metabolites on endocrine-dependent and endocrine-independent breast cancer cells, Tumor Biol 1991;12:149-158.
27. Formelli F, Clcrici M, Campa T, Di Mauro MG, Magni A, Mascotti G, Moglia D, De Palo G, Costa A, Vc-roncsi U: Five-year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations, J Clin Oncol 1993; 11: 2036-2042.
28. Daniel PC, Gaskell J, Bishop H, Campbell C, Nicholson R: Determination of tamoxifen and biologically active metabolites in human breast tumor and plasma, Eur J Cancer Clin Oncol 1981;17:1183-1189.
29. Burton DA: Studies of conditions and mechanism of the diphenylam-inc reaction for the colorimetric determination of deoxyribonucleic acid, BiochcmJ 1956;62:315-323.
30. Drewinko B, Loo TL, Brown B: Combination chemotherapy in vitro with Adriamycin, Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells, Cancer Biochem Biophys 1976;1:187-195.
31. Bhuyan BK, Adams EG, Johnson M: Synergistic combination of me-nogarol and mclphalan and two other drug combination, Invest New Drugs 1985;3:233-244.
32. Coradini D, Biffi A, Cappelletti V, Di Fronzo G: Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells, Anticancer Res 1994;14:1059-1064.
33. Marth C, Bock G, Daxenbichler G: Effect of 4-hydroxyphenylrctinam-ide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells, J Natl Cancer Inst 1985;75:871-875.
34. Fontana JA, Miranda D, Burrow Mezu A: Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of an Mr 39,000 protein, Cancer Res 1990;50:1977-1982.
35. Swisshclm K, Ryan K, Lee X, Tsou HC, Pcacocke M, Sager R: Down-regulation of retinoic acid receptor-p in mammary carcinoma cell lines and its up-regulation in scnescing normal mammary epithelial cells, Cell Growth Differ 1994;5:133-141.
36. Pellegrini R, Mariotti A, Tagliabue E, Brcssan R, Bunone G, Coradini D, Della Valle G, Formelli F, Cleris L, Radice P, Picrotti M, Colnaghi I, Menard S: Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)reti-namide, Cell Growth Differ 1995;6: 863-869.
37. Marth C, Daxenbichler G, Dapunt O: Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells, J Natl Cancer Inst 1986;77:1197-1202.
38. Widschwendter M, Daxenbichler G, Dapunt O, Marth C: Effects of retinoic acid and y-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells, Cancer Res 1995;55:2135-2139.
39. Glass CK, Devary OV, Roscnfeld MG: Multiple cell type-specific proteins differentially regulate target sequence recognition by the a-retinoic acid receptor, Cell 1990;63:729-738.
40. Bcdo G, Santisteban P, Aranda A: Retinoic acid regulates growth hormone gene expression, Nature 1989; 339:231-234.
41. Thompson C, Challoner P, Neiman P: Expression of the c-myc protooncogene during cellular proliferation, Nature 1986;319:374-380.
42. Spom MB, Roberts AB: Interactions of retinoids and transforming growth factor-p in regulation of cell differentiation and proliferation, Mol Endocrinol 1991;5:3-8.
43. Colletta AA, Wakefield LM, Howell K, van Roozendaal E, Danielpour D, Ebbs SR, Sporn MB, Baum M: Antiestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts, Br J Cancer 1990;62:405-409.
44. Van dcr Burg B, Insbrucker L, Van Sclm-Miltenburg AJP: Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cell lines, Cancer Res 1990;50:7770-7774.
45. Wcthcrall NT, Taylor CM: The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells, Eur J Clin Oncol 1986;22:53-59.
46. Ratko TA, Detrisac CJ, Dinger NM, Thomas CF, Kelloff GJ, Moon RC, Wosikowski C, Maxwell SA, Muk-hopadhyay T: Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid, Exp Cell Res 1994;214:67-74.